ACST
Acasti Pharma
–
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 21.02M; Volume: 1.04M; AvgVol 3m: 6.02M; Beta: –;
Cost estimate:
P/E: –; EPS: –; EPS growth quarter/prev quarter: ;
EPS growth this year: 30.30%; EPS growth past 5 years: ;
EPS ttm: -0.24;
P/S: ; P/B: 1.74; P/Cashflow: ; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 9.29%; Insider Transactions:0.00%;
Institutional Ownership: 6.09%; Institutional Transactions: ;
Data update: 07.10.2020.